L-371,257

L-371,257' is a chemical compound that acts as a selective antagonist for the oxytocin receptor. It is primarily used in scientific research to study the role of oxytocin in various physiological and behavioral processes.
Chemical Properties[edit]
L-371,257 has a molecular formula of C 23H 28N 2O 3. It is a small molecule that can cross the blood-brain barrier, making it useful for central nervous system studies.
Mechanism of Action[edit]
As an oxytocin receptor antagonist, L-371,257 binds to the oxytocin receptor and inhibits its activity. This prevents oxytocin from exerting its effects, which include modulation of social behavior, stress responses, and reproductive functions.
Research Applications[edit]
L-371,257 is used in various research settings, including:
- **Behavioral Studies**: To investigate the role of oxytocin in social bonding, aggression, and maternal behaviors.
- **Neuroscience**: To study the effects of oxytocin on brain function and its potential therapeutic uses in conditions like autism spectrum disorder and schizophrenia.
- **Reproductive Health**: To explore the role of oxytocin in labor and lactation.
Pharmacokinetics[edit]
L-371,257 is administered in research settings via various routes, including intravenous and intraperitoneal injections. Its ability to cross the blood-brain barrier makes it particularly useful for central nervous system studies.
Safety and Toxicity[edit]
As with many research chemicals, the safety and toxicity profile of L-371,257 is not fully established. It is used under controlled conditions in laboratory settings to minimize potential risks.
See Also[edit]
References[edit]
External Links[edit]
-
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian